Roche to Acquire BioVeris for US$21.50 per share
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 83 (Table of Contents)
Published: 7 May-2007
DOI: 10.3833/pdr.v2007.i83.354 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Roche Diagnostics entered into acquisition agreement to acquire BioVeris, thus strengthening its product portfolio in the areas of life sciences research and development, patient self-testing, veterinary testing, drug discovery, drug development and clinical trials...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS